Year | Detail |
1876 |
Lilly was founded. |
1917 |
Lilly Partnered with American Red Cross, to set up a medical field hospital in France, to treat wounded soldiers during World War I. |
1923 |
Lilly introduced Iletin (animal-source insulin, Lilly), the world’s first commercially available insulin product, for the treatment of diabetes – then a fatal disease with no effective treatment options. |
1928 |
It introduced a liver-extract product to treat pernicious anemia, a life-threatening blood disorder, that served as a standard of therapy for decades. |
1955 |
Lilly started to manufacture and distribute the Salk Polio Vaccine globally. |
1958 |
Lilly introduced Vancocin (Vancomycin hydrochloride, Lilly), an antibiotic for infections associated with certain types of resistant bacteria. |
1961 |
Introduced Velban (vinblastine, Lilly), the company’s first oncology drug was introduced for the treatment of several types of cancer. |
1982 |
Lilly introduced Humulin (human insulin derived from rDNA, Lilly), insulin identical to that produced by the human body. |
1986 |
Lilly launched Prozac (fluoxetine hydrochloride, Lilly) in Belgium as a treatment for clinical depression. |
1996 |
The company introduced Gemzar (gemcitabine hydrochloride, Lilly) a drug for the treatment of pancreatic and non-small-cell lung cancer and Zyprexa (olanzapine, Lilly) for the treatment of schizophrenia. |
2003 |
Lilly launched the Lilly MDR-TB Partnership to help address the rising burden of multidrug-resistant tuberculosis in some of the world’s most underserved communities. |
2004 |
Lilly introduced Cymbalta (duloxetine hydrochloride, Lilly) as a treatment for major depressive disorder. |
2011 |
The Lilly NCD Partnership was created to fight the rising burden of non-communicable diseases. |
2018 |
The company opened the Lilly Diabetes Solution Center in the U.S. |
2019 |
Lilly acquired Loxo Oncology to broaden treatment options for patients with cancer. |